| 726548 |
FRONTIERS IN ONCOLOGY |
Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients |
2021-08-09 |
10.3389/fonc.2021.668707 |
Zhang Yawei, Wang Han, Xu Xiaoyu, Liu Huifang, Hao Tengfei, Yin Songcheng, Zhang Changhua, He Yulong |
| 726547 |
FRONTIERS IN ONCOLOGY |
Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma |
2021-08-09 |
10.3389/fonc.2021.730615 |
Hu Chunxiao, Zhang Yanli, Zhang Mengjiao, Li Tingting, Zheng Xin, Guo Qining, Zhang Xin |
| 726546 |
FRONTIERS IN ONCOLOGY |
Unilateral Subfrontal Approach for Giant Tuberculum Sellae Meningioma: Single Center Experience and Review of the Literature |
2021-08-09 |
10.3389/fonc.2021.708235 |
Xiao Feng, Shen Jie, Zhang Luyuan, Yang Jiqi, Weng Yuxiang, Fang Zebin, Zhang Chao, Ye Hongxing, Zhan Renya, Zheng Xiujue |
| 726545 |
FRONTIERS IN ONCOLOGY |
Adaptive Attention Convolutional Neural Network for Liver Tumor Segmentation |
2021-08-09 |
10.3389/fonc.2021.680807 |
Luan Shunyao, Xue Xudong, Ding Yi, Wei Wei, Zhu Benpeng |
| 726544 |
FRONTIERS IN ONCOLOGY |
Oleic Acid and Insulin as Key Characteristics of T2D Promote Colorectal Cancer Deterioration in Xenograft Mice Revealed by Functional Metabolomics |
2021-08-09 |
10.3389/fonc.2021.685059 |
Zhang Ying, Wang Di, Lv Bo, Hou Xiaoying, Liu Qiwei, Liao Chuyao, Xu Ruijie, Zhang Yuxin, Xu Fengguo, Zhang Pei |
| 726543 |
FRONTIERS IN ONCOLOGY |
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead |
2021-08-09 |
10.3389/fonc.2021.689839 |
Abdoli Shadbad Mahdi, Hosseinkhani Negar, Asadzadeh Zahra, Derakhshani Afshin, Karim Ahangar Noora, Hemmat Nima, Lotfinejad Parisa, Brunetti Oronzo, Silvestris Nicola, Baradaran Behzad |
| 726542 |
FRONTIERS IN ONCOLOGY |
Imaging Features of Primary T Cell Lymphoma in Bone: A Case Report and Review of Literature |
2021-08-09 |
10.3389/fonc.2021.690819 |
Yu Suli, Xu Jianqiang |
| 726541 |
FRONTIERS IN ONCOLOGY |
Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis |
2021-08-09 |
10.3389/fonc.2021.700165 |
Yang Chao, Xu Chang, Li Xiang, Zhang Yaowen, Zhang Simeng, Zhang Tongyu, Zhang Yingshi |
| 726540 |
FRONTIERS IN ONCOLOGY |
Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective Analysis |
2021-08-09 |
10.3389/fonc.2021.621594 |
Gou Qiheng, Fu Shengya, Xie Yuxin, Zhang Mengni, Shen Yali |
| 726539 |
FRONTIERS IN ONCOLOGY |
Identification of Key Genes Mutations Associated With the Radiosensitivity by Whole Exome Sequencing in Pancreatic Cancer |
2021-08-09 |
10.3389/fonc.2021.697308 |
Hu Bin, Ma Xiumei, Huang Renhua, Wu Zheng, Lu Jun, Guo Yuntao, Tang Jianmin, Ma Chunhui, Ma Jun, Zhang Lei, Bai Yongrui |
